SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company with a current market capitalization of approximately $60 million, has announced the pricing of its public offering ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on advancing cardiac care, announced that the underwriter of its recent public offering exercised its option to purchase an additional ...

After giving effect to the exercise of the over-allotment option, the total number of shares sold by HeartBeam in the public offering increased to 6,746,386 shares and gross proceeds increased to ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, will hold a ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care, announced the pricing of its public offering of 5,882,353 shares at $1.70 per share, expecting to raise $10 million ...

SANTA CLARA, Calif., February 13, 2025--HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock As the U.S. stock market navigates a mixed landscape of earnings ...

HeartBeam system was recently cleared by the U.S. Food and Drug Administration (FDA) for comprehensive arrhythmia assessment 510(k) application submitted to the FDA for the Company’s ...

SANTA CLARA, Calif., February 13, 2025--HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock As the U.S. stock market navigates a mixed landscape of earnings ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today ...

HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock ...

Failed to fetch dynamically imported module: https://uk.finance.yahoo.com/assets/_app/immutable/nodes/106.BfLtBoPo.js ...